Compare TOI & DSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOI | DSU |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | 641 | N/A |
| Industry | Medical/Nursing Services | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 579.9M | 605.4M |
| IPO Year | N/A | 1998 |
| Metric | TOI | DSU |
|---|---|---|
| Price | $5.87 | $9.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.67 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 311.2K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.15 | N/A |
| Revenue Next Year | $25.77 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.32 | $9.31 |
| 52 Week High | $6.11 | $10.64 |
| Indicator | TOI | DSU |
|---|---|---|
| Relative Strength Index (RSI) | 64.43 | 48.28 |
| Support Level | $3.28 | $9.61 |
| Resistance Level | N/A | $9.77 |
| Average True Range (ATR) | 0.37 | 0.06 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 78.10 | 49.92 |
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
Blackrock Debt Strategies Fund Inc is a closed-end management investment company. Its primary investment objective is to seek to provide current income by investing in a diversified portfolio of U.S. companies debt instruments, including senior and subordinated corporate loans, both secured and unsecured, which are rated in the lower rating categories of the established rating services or unrated debt instruments, which are in the judgment of the investment adviser of equivalent quality. The Fund may invest directly in debt instruments or synthetically through the use of derivatives. The Fund's secondary investment objective is to seek to provide capital appreciation.